Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Ins… (NCT03436212) | Clinical Trial Compass
CompletedNot Applicable
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
France24 participantsStarted 2017-09-05
Plain-language summary
This study aims at describing the glucose level by automated glucose sensors and correlating it with insulin delivery and meals over 14 days in insulin-requiring T2D patients living in real-life conditions.
Who can participate
Age range50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Selection criteria:
* Type 2 Diabetes diagnosed for at least 5 years
* Treated with insulin pump for at least 6 months
* 7.5% ≤ HBA1c ≤ 10% (last available value dated less than 3 months)
* Having given his/her free, express and informed consent to participate to the study
Inclusion Criteria:
* 7.5% ≤ HBA1c ≤ 10% (result of the dosage performed at selection visit)
* Daily insulin requirement ≤ 1.5U/kg/day
* Having been compliant to take pictures of his/her meals and snacks over the 3 days prior to the inclusion visit
Non-selection/Non-inclusion criteria:
* Pregnant or breastfeeding woman
* Comorbidity which, in the investigator's opinion, could jeopardize the study completion
* Patient with difficulties to understand the study procedures or deemed unfit, by the Investigator, to comply with operating instructions of CGM equipment.
What they're measuring
1
Relationships between glucose levels and insulin doses